Surgical sales & Uro/Gyn sales













Whatever you do, do not accept a TM position with Karl Storz URO/GYN
In Detroit, Olympus has 90 percent market share and all Urologists
There know that Blue Light lost its FDA Reimbursement effective January 1st.
 






Whatever you do, do not accept a TM position with Karl Storz URO/GYN
In Detroit, Olympus has 90 percent market share and all Urologists
There know that Blue Light lost its FDA Reimbursement effective January 1st.

This is probably the Detroit surgical rep posting this. He likely doesn't want to lose urology out of his bag again.

The KS 90% competitive market share? Sounds like nothing but upside and opportunity.
 






Whatever you do, do not accept a TM position with Karl Storz URO/GYN
In Detroit, Olympus has 90 percent market share and all Urologists
There know that Blue Light lost its FDA Reimbursement effective January 1st.

This is totally the Detroit surgical rep posting this. Any urology rep would know that there hasn't been reimbursement for blue light in a year. This hasn't stopped accounts from trying the technology.

With regards to market share. The fact that Olympus has so much business is just more opportunity for the new rep to come in and win business.